July 2, 2019 – Oxford, UK – 2nd July 2019 Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotechnology Ltd (CHAIN) and the University of Oxford to develop live biotherapeutics that support oral delivery for OVM’s […]
The post Cancer vaccine firm Oxford Vacmedix announces collaboration & Innovate UK grant appeared first on SynBioBeta.